Showing 1 - 10 of 29
With the current Article 50 extension deadline of 31 October 2019 looming against a complex and uncertain political backdrop, and talks between the UK and EU continuing without any clear sign of a definitive outcome, the possibility of a no-deal Brexit remains at an all-time high.
Boris Johnson’s first Queen’s Speech delivered on Monday 14 October 2019 - dominated by Brexit-related legislation - included the Medicines and Medical Devices Bill (the Bill).
Following today's Queen's Speech, we have officially responded to some key domestic legislation relating Air Traffic Management and Unmanned Aircraft Bill, and the Medicines and Medical Devices Bill.
In a week that is likely to be dominated by ongoing Brexit negotiations and timelines, we have today been provided with this Government’s priorities and legislative programme in the Queen’s Speech which took place this morning.
IBM recently announced its latest blockchain initiative in partnership with KPMG, Merck and Walmart. The consortium’s goal is to develop a pharmaceutical blockchain platform that can track drugs as they move through the global supply chain, from manufacturer to end user.
We are pleased to announce that we have grown our presence in Portugal by merging with boutique Portuguese firm N. Maldonado Sousa & Associados. The merged firm will move into our existing Lisbon office in the centre of the city.
A roundup of recent cyber related developments, including the black box effect in ship risk profiling, GDPR fines from the ICO, silent cyber risks, cyber threats to the life sciences sector, insuring the emerging offshore digital assets industry and claims transformation in Latin America.
In October 2018, the Secretary of State for Health and Social Care, Matt Hancock, outlined his vision for the future of healthcare through a digital patient journey, in order to provide better patient care, improve efficiency and reduce operational costs. The plans encompass a digital process for the patient from pre-diagnosis to discharge.
On 1 May 2019, Charles River Laboratories revealed it was the victim of a ‘sophisticated and well resourced’ hacking attack and resulting data breach, discovered in mid-March and thought to have compromised about 1% of the company’s client data.
We are pleased to announce that the publication of the 2019 edition of The Legal 500 Europe, Middle East and Africa has seen us build on our 2018 success. Kennedys has been ranked in 14 practice areas, including three new rankings for our Paris office (dispute resolution, healthcare and life sciences and insurance), and a ‘top tier’ ranking for aviation in Belgium.